Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy

Microbial Drug Resistance

Volumn 10, Issue 3, 2004, Pages 264-268

  Cocuzza, Clementina E ^a   Lanzafame, A ^b   Sisto, F ^b   Broccolo, F ^a   Mattina, R ^b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFIXIME; CEFTIBUTEN; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLAVULANIC ACID; ERYTHROMYCIN; MACROLIDE; PENICILLIN G; ROKITAMYCIN;

ACUTE PHARYNGOTONSILLITIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CONTROLLED STUDY; ERADICATION THERAPY; GENETIC SELECTION; HUMAN; INTERNALIZATION ASSOCIATED PRTF1 GENE; MAJOR CLINICAL STUDY; PHARYNGITIS; PHENOTYPE; PRIORITY JOURNAL; STREPTOCOCCUS PYOGENES; THROAT CULTURE; TONSILLITIS;

ACUTE DISEASE; ADHESINS, BACTERIAL; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; HUMANS; MICROBIAL SENSITIVITY TESTS; PHARYNGITIS; POLYMERASE CHAIN REACTION; STREPTOCOCCUS PYOGENES; TONSILLITIS; TREATMENT FAILURE;

BACTERIA (MICROORGANISMS); STREPTOCOCCUS PYOGENES;

EID: 4644300761     PISSN: 10766294     EISSN: None     Source Type: Journal    
DOI: 10.1089/mdr.2004.10.264     Document Type: Article

References (31)

1. Beckert, S., B. Kreikemeyer, and A. Podbielski. 2001. Group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect. Immun. 69:534-537.
2. Brandt, C.M., F. Allerberger, B. Spellerberg, R. Holland, R. Lutticken, and G. Haase. 2001. Characterization of consecutive Streptococcus pyogenes isolates from patients with pharyngitis and bacteriological treatment failure: Special reference to prtF1 and sic/drs. J. Infect. Dis. 183:670-674.
3. Cellesi, C., S. Chigiotti, A. Zanchi, et al. 1996. Susceptibility to macrolide and beta-lactam antibiotics of Streptococcus pyogenes strains isolated over a four year period in central Italy. J. Chemother. 8:188-192.
4. Cocuzza, C.E., R. Mattina, A. Mazzariol, et al. 1997. High incidence of erythromycin-resistant Streptococcus pyogenes in Monza (North Italy) in untreated children with symptoms of acute pharyngo-tonsillitis: an epidemilogical and molecular study. Microb. Drug Resist. 3:381-388.
5. Cornaglia, G., M. Ligozzi, A. Mazzariol, et al. 1996. Rapid increase of resistance to erythromycin and clindamycin in Streptococcus pyogenes in Italy 1993-1995. Emerg. Infect. Dis. 2:331-334.
6. Dillon, H.C. Jr. 1987. Streptococcal pharyngitis in the 1980s. Pediatr. Infect. Dis. 6:123-130.
7. Duval J. 1985. Evolution and epidemiology of MLS resistance. J. Antimicrob. Chemother. 16:137-149.
8. Facinelli, B., C. Spinaci, G. Magi, E. Giovanetti, and P.E. Varaldo. 2001. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30-33.
9. Goodfellow, A.M., M. Hibble, S.R. Talay, B. Kreikemeyer, B.J. Currie, K.S. Sriprakash, and G.S. Chatwal. 2000. Distribution and antigenicity of fibronectin binding proteins (SfbI and SfbII) of Streptococcus pyogenes clinical isolates from the northern territory, Australia. J. Clin. Microbiol. 38:389-392.
10. Hsuech, P.R., H.M. Chen, A.Y. Huang, et al. 1995. Decreased activity of erythromycin against Streptococcus pyogenes in Taiwan. Antimicrob. Agents Chemother. 39:2239-2242.
11. Jarvinen, H.A., A. Nissinen, and P. Huovinen. 1989. Erythromycin resistance in Group A streptococci. Lancet 1:1022-1023.
12. Katerov, V., A. Andreev, C. Schalen, and A.A. Totolian. 1998. Protein F, a fibronectin-binding protein of Streptococcus pyogenes, also binds human fibrinogen: isolation of the protein and mapping of the binding region. Microbiology 144:119-126.
13. Kliegman, R.M., and R.D. Feigin. 1992. Streptococcal Infections. In Nelson-Textbook of paediatrics, 14th ed. W.B. Saunders Company, Philadelphia, PA, p. 698.
14. Komaroff, A.L., M.D. Aronson, T.M. Pass, et al. 1983. Serologic evidence in chlamydial and mycoplasmal pharyngitis in adult. Science 222:927-929.
15. Ma, X., H. Kikuta, N. Ishiguro, M. Yoshioka, T. Ebihara, T. Murai, I. Kobayashi, and K. Kobayashi. 2002. Association of the prtF1 gene (encoding fibronectin-binding protein F1) and the sic gene (encoding the Streptococcal inhibitor of complement) with emm types of group A streptococci isolated from Japanese children with pharyngitis. J. Clin. Microbiol. 40:3835-3837.
16. Maruyama, S.H., H. Yoshioka, K. Fujita, et al. 1979. Susceptibility of Group A streptococci to antibiotics: prevalence of resistance to erythromycin in Japan. Am. J. Child. 133:1143-1145.
17. Miyamoto, Y., K. Takizawa, A. Matsushima, et al. 1978. Step-wise acquisition of multiple drug resistance by beta-hemolytic streptococci and differences in resistance pattern by type. Antimicrob. Agents Chemother. 13:399-404.
18. Molinari, G., M. Rohde, S.R. Talay, G.S. Chhatwal, S. Beckert, and A. Podbielski. 2001. The role played by the group A Streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol. Microbiol. 40:99-114.
19. National Committee for Clinical Laboratory Standards. 1995. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M7-A3, National committee for Clinical Laboratory Standards, Villanova, PA.
20. National Committee for Clinical Laboratory Standards. 1995. Performance Standards for Antimicrobial Susceptibility testing. 5th Informational Supplement, NCCLS Document M 100 S6 Vol. 15 N° 14.
21. Neeman, R., N. Keller, A. Barzilai, Z. Korenman, and S. Sela. 1998. Prevalence of the internalization-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974-1977.
22. Phillips, G., D. Parratt, G.V. Orange, et al. 1990. Erythromycin- resistant Streptococcus pyogenes. J. Antimicrob. Chemother. 25:723-724.
23. Podbielski, A., and B. Kreikemeyer. 2001. Persistence of group A streptococci in eukaryotic cells-a safe place? Lancet 358:3-4.
24. Quinn, R.W. 1982. Epidemiology of group A streptococci infections - the changing frequency and severity. Yale J. Biol. Med. 55:265-270.
25. Radetsky, M. 1993. Group A streptococcal infections. In Gellis and Kagan's Current Paediatric Therapy, 14th ed. W.B. Saunders Company, Philadelphia, PA, p. 557.
26. Rondini, G., C.E. Cocuzza, M. Cianflone, A. Lanzafame, L. Santini, and R. Mattina. 2001. Bacteriological and clinical efficacy of various antibiotics used in the treatment of streptococcal pharyngitis in Italy. An epidemiological study. J. Antimicrob. Agents. 18:9-17.
27. Seppala, H., A. Nissinen, H. Jarvinen, et al. 1993. Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J. Antimicrob. Chemother. 32:885-891.
28. Seppala, H., A. Nissinen, H. Jarvinen, et al. 1992. Resistance to erythromycin in group A streptococci. N. Engl. J. Med. 326:292-297.
29. Stingemore, N., G.R. Francis, M. Toohey, et al. 1989. The emergence of erythromycin resistance in Streptococcus pyogenes in Fremantle, Western Australia. Med. J. Austr. 150:626-631.
30. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but susceptible to clindamycin: A common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
31. Tenover, F.C., R.D. Arbeit, R.V. Goering, et al. 1995. Interpreting chromosomal DNA restriction patterns procedure by pulsed-field gel electrophoresis: Criteria for bacterial typing. J. Clin. Microbiol. 33:2233-2239.